Athanor Capital, LP Replimune Group, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$30.22 - $45.57 $398,390 - $600,749	-13,183 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.5 - $52.65 $38,399 - $86,030	-1,634 Reduced 11.03%	13,183 $503,000
Q3 2020 Nov 16, 2020	SELL	$18.85 - $27.0 $104,787 - $150,093	-5,559 Reduced 27.28%	14,817 $341,000
Q2 2020 Aug 13, 2020	BUY	$9.76 - $25.95 $198,869 - $528,757	20,376 New	20,376 $506,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.